EVAX Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own EVAX shares is N/A, representing N/A of the company's common stock.

UBS GROUP AG, in the last quarter, reduced its stake in EVAX by -93.08% restricting it's holding to 277 shares of worth nearly $190.00. MORGAN STANLEY also lessened -100% of the EVAX shares from its portfolio, reducing its holding to 0 shares of worth -. SUSQUEHANNA INTERNATIONAL GROUP, LLP also shunned EVAX shares holding by -100% last quarter which brought its holding to 0 shares worth -.

As per its latest 13F filing, increased its stake in EVAX by 100% in the last quarter. The institutional holder raised its holding to 337.34 thousand shares having worth more than $231.31K. RHUMBLINE ADVISERS also added 37.93% more shares of EVAX to its portfolio, raising its holding to 2.91 thousand shares of worth $2.00K. CITADEL ADVISORS LLC also increased its EVAX shares holding by 100% which brought its holding to 1.3 thousand shares worth $891.00.

The insider with the most stakes in EVAX is N/A , N/A at the company. Additionally, EVAX stock is highly held by N/A N/A and N/A N/A among others.

Company executives, directors, and other insiders own N/A percent of Evaxion Biotech A/S's stock. Within the last six months, there have been 0 transaction(s) in which EVAX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

There have been 0 transaction(s) during the past 6-months in which Evaxion Biotech A/S insiders have bought stock, totalling 0 shares

Around 0 Evaxion Biotech A/S shares are held by insiders, which represents about N/A of EVAX stock.

EVAX N/A, N/A holds the largest portfolio of the company's shares. EVAX shares owned by N/A total nearly -.

is the largest institutional owner in EVAX which holds 337.34 thousand shares worth $231.31K or 12.2% of the total EVAX shares outstanding followed by RHUMBLINE ADVISERS with ownership of 2.91 thousand shares representing 0.11% of the EVAX ownership. CITADEL ADVISORS LLC is the third largest stakeholder with 1.3 thousand shares or 0.05% of the ownership worth more than $891.00.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the EVAX is concerned, it is a stock which is not optionable.

Number of EVAX shares short is 196.03K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 1.17M shares of EVAX are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, EVAX has 35.89M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for EVAX is 1.07.